New research highlights the potential of DMT (N,N-dimethyltryptamine), a naturally occurring psychedelic compound, to aid stroke recovery. Found in plants and the human brain, and a key psychoactive ingredient in ayahuasca, studies—primarily in animal models and cell cultures—suggest that DMT helps reduce stroke damage by stabilizing the blood-brain barrier and mitigating neuroinflammation.

Meanwhile, the New York cannabis market is experiencing significant growth. The state's legal cannabis retailers set a new monthly sales record in August, hitting $214.4 million, a substantial increase from the previous months' sales. To support the expanding market, the Cannabis Control Board recently approved 33 new licenses, with 11 of them allocated to cultivators to boost production.